Sat.Mar 23, 2024

article thumbnail

High Frequency of OTC Product Misuse in Older Adults Highlights Areas for Pharmacists to Address

Drug Topics

Adults aged 65 years and older are the largest group of consumers of OTC medications.

212
212
article thumbnail

Pharmacist's Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education

Pharmacy Times

Shared decision making with patients is a key component of RSV vaccination, which can bring challenges and opportunities.

Vaccines 153
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Emotional Intelligence Helps Pharmacists Handle Controlled Substances Concerns

Drug Topics

Pharmacists must uphold their “corresponding responsibility” to address controlled substance concerns among patients while balancing safety and respect, said Mark Garofoli at this year’s American Pharmacists Association Annual Meeting & Exposition.

article thumbnail

Changing Mindset Is Crucial for Clinicians to Effectively Implement New Weight Management Medications

Pharmacy Times

In addition to improved efficacy, newer generations of anti-obesity medications have significantly improved safety concerns.

149
149
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Slideshow: Examining Preferences and Attitudes Around OTC Naloxone

Drug Topics

The first nonprescription, OTC naloxone nasal spray (Narcan) was approved by the FDA in March 2023.

FDA 123
article thumbnail

Expert: Pharmacogenomics Could Be Particularly Beneficial in the Psychiatric Setting

Pharmacy Times

Pharmacogenomics could help streamline prescribing and dosing for psychiatric medications, avoiding the trial-and-error process common with these medications.

123
123
article thumbnail

Expert Reviews New Data, Updates in Psychedelic Medicines

Pharmacy Times

Sa'ed Al-Olimat, PharmD, also discussed the potentially groundbreaking shift for MDMA expected later in 2024.

120
120